Skip to Content

Graybug Vision, Inc.

Merger

  • Date:
  • 11/22/2022
  • Company Name:
  • Graybug Vision, Inc.
  • Stock Symbol:
  • GRAY
  • Company Name - Buyer:
  • CalciMedica Inc.
  • Status:
  • Investigating
  • Merger Announcement Date:
  • 11/21/2022

Case Finder

Locate any case using the tools below.

NEW YORK, November 22, 2022 – Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of Graybug Vision, Inc. (NASDAQ: GRAY) (“Graybug”) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by CalciMedica Inc. (“CalciMedica”).

On November 21, 2022, Graybug announced that it had entered into an agreement to be acquired by CalciMedica in an all-stock deal. Pursuant to the merger agreement, Graybug equity holders are expected to collectively own approximately 29% of the combined company, and pre-merger CalciMedica equity holders are expected to collectively own approximately 71% of the combined company, in each case, on a fully diluted basis using the treasury stock method. The deal is expected to close in the first quarter of 2023.

Bragar Eagel & Squire is concerned that Graybug’s board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Graybug’s stockholders.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Graybug Vision. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: